Private access

Strategic Commitee

Director of the ANRS (France Recherche Nord&Sud Sida-HIV Hépatites) since 2005. Director of I3M (Immunology, Inflammation, Infectious Diseases and Microbiology) since 2008. French Interministerial Coordinator of the fight against Ebola (2014-2015) Previously head of the department of internal medicine at the CHU (University Hospital) Paris Sud (AP-HP), Professor Delfraissy demonstrates a long and broad professional experience in infectious diseases and public health.

Among other accomplishments he has presided several scientific committees: Scientific Board Sidaction, Fondation Recherche Médicale, the Experts Committee of the Ministry of Health for the treatment and care of people living with HIV. In addition to his role as faculty member, in his capacity of Professor of immunology and internal medecine, he presided and organized a number of international conferences dedicated to scientific research and he has published more than 500 articles in the domain of immunology, internal medicine, and HIV infection (His Impact factor H from Web of Science 68).

His investment in research led to high-level responsibilities in various research programmes and clinical trials within ANRS (France REcherche Nord & sud Sida-hiv Hépatites). Professor Delfraissy is particularly involved in questions of public health and infectious diseases in resource-limited settings, as a Unaids and WHO expert, Head of the Esther programme in Cambodia and of the clinical research site of the ANRS in Sud-East Asia. He is member of the WHO STACs on HIV Hepatitis, Ebola and ZIKA. Professor Delfraissy is currently Director of the ANRS and of the Institut of Immunology, Inflammation, Infectious Diseases and Microbiology of Inserm-AVIESAN, and President of the committee of biomedical research and public health in Bicètre Hospital (AP-HP).

Since July 2014, he organizes and coordinates the translational research on Ebola by the French research teams within the Aviesan network. On 20 October 2014, Professor Delfraissy was nominated by the Prime Minister as Coordinator of all international and national operations in response to the Ebola epidemic until December 2015. He has been nominated Officer of the National Order of the Légion d’Honneur in 2010. Jean-François Delfraissy chairs in the Strategic Committee of the VRI.


Yves Lévy is a MD, PhD and Professor of clinical immunology. Yves Lévy is a specialist in immunology, a physician who is also a researcher and academic.

His research activity is directed at understanding the development of the immune system and its pathology. He has also coordinated and developed some twenty national and international clinical trials of immunotherapies and vaccines for HIV infection, certain immunodeficiencies and infectious diseases. His scientific career has always combined basic and clinical research.

Since 1985 he has worked successively in several Inserm research units. Since 1999, he has been Director of the team “Lymphoid Development under Normal Conditions and Under HIV Infection” in Inserm Unit 955. From 1996 to the present day Yves Lévy has directed the Department of Clinical Immunology and Infectious Diseases at Henri Mondor de Créteil Hospital.

In 2006, Yves Lévy became Scientific Director of the vaccine programme of the French National Agency for Research on AIDS and Viral Hepatitis (ANRS). In 2011, he created the “Vaccine Research Institute” labex (laboratory of excellence) under the Investissement d’Avenir (Investment for the Future) programme. His science programme is based on recent advances in basic immunology, genomics and the knowledge of systems biology, and the development of innovative tools for evaluating the immune response.

From 2010 to 2012, Yves Lévy was Vice-Dean of the Faculty of Medicine, Paris-Est Créteil University (UPEC). He subsequently became a special advisor to the Minister for Higher Education and Research. Yves Lévy is executive director of the VRI, chairman and CEO of the Inserm.


Honorary President

Co-discoverer of the Human Immunodeficiency virus (HIV-1) in 1983, Françoise Barré-Sinoussi is recognized for her huge contribution to HIV/AIDS research for which she was awarded with the 2008 Nobel Prize in medicine.

She is research Director of Exceptional Grade at Inserm (French National Institute of Health and Medical Research) and Professor at the Institut Pasteur where she was the Director of the "Regulation of Retroviral Infections" Unit until August 2015. She has been Involved in retrovirology research since she first began working at the Institut Pasteur in 1971. For more than three decades she has been internationally recognized for the huge contribution she has made to HIV/AIDS research.

Her work has been focused on better understanding which responses should be elicited, including at the mucosa level, to prevent HIV infection and/or disease progression. Françoise Barré-Sinoussi has been strongly committed throughout her career, to promoting the integration of HIV research with public health, echnology transfers and human resources capacity building in resource-limited countries.

She has particularly focused on this area of research through her on-going work with the Institut Pasteur International Network and the coordination of the ANRS research programs in Cambodia and Vietnam.

She is also largely recognized for her engagement in advocating for universal access to health for and for defending human rights, especially those of the most vulnerable populations.